Minor Allele of the APOA4 Gene T347S Polymorphism Predisposes to Obesity in Postmenopausal Turkish Women

Overview

Journal Mol Biol Rep

Specialty Molecular Biology

Date 2012 Oct 26

PMID 23096082

Citations 4

Authors

Filiz Guclu-Geyik

Altan Onat

Neslihan Coban

Evrim Komurcu-Bayrak

Vedat Sansoy

Gunay Can

Nihan Erginel-Unaltuna

Affiliations

Soon will be listed here.

Abstract

The aim of this study was to examine the relationship between APOA4 gene T347S polymorphism with obesity measures and serum lipids in Turkish adults. Randomly selected sample of 1,554 adults (754 men, mean age 50.4 ± 11.9 years and 800 women, mean age 49.6 ± 11.8 years) were included in the study. 346 Women (43.2 %) were postmenopausal. Genotyping was performed by using hybridization probes in real-time PCR. Not men but postmenopausal women, carrying the S347 allele, were associated with 1.5 kg/m(2) higher BMI (P = 0.016) and 3.6 cm wider waist circumference (P = 0.005) than postmenopausal T347 homozygotes, controlled for covariates. Logistic regression analyses of this polymorphism, adjusted for age, fasting triglyceride, smoking status, alcohol consumption and physical activity disclosed the rare allele to be associated with obesity in postmenopausal women at an odds of 1.80 (95 % CI 1.09-2.97; P = 0.021). Serum apoB level was lower in S347 allele carriers (110.9 ± 2.9 mg/dL) than in T347 homozygotes (119.0 ± 2.4 mg/dL; P = 0.035) in men but not women. APOA4 T347S polymorphism was unrelated to lipids and other lipoproteins in either gender. The APOA4 S347 allele predisposes to obesity and high waist circumference in Turkish postmenopausal women. ApoB levels are lower only in men in S347 allele carriers.

Citing Articles

Biological underpinnings of breastfeeding challenges: the role of genetics, diet, and environment on lactation physiology.

Lee S, Kelleher S Am J Physiol Endocrinol Metab. 2016; 311(2):E405-22.

PMID: 27354238 PMC: 5005964. DOI: 10.1152/ajpendo.00495.2015.

A long non-coding RNA, APOA4-AS, regulates APOA4 expression depending on HuR in mice.

Qin W, Li X, Xie L, Li S, Liu J, Jia L Nucleic Acids Res. 2016; 44(13):6423-33.

PMID: 27131369 PMC: 5291254. DOI: 10.1093/nar/gkw341.

Apolipoprotein A-IV: a protein intimately involved in metabolism.

Wang F, Kohan A, Lo C, Liu M, Howles P, Tso P J Lipid Res. 2015; 56(8):1403-18.

PMID: 25640749 PMC: 4513983. DOI: 10.1194/jlr.R052753.

Vertical sleeve gastrectomy restores glucose homeostasis in apolipoprotein A-IV KO mice.

Pressler J, Haller A, Sorrell J, Wang F, Seeley R, Tso P Diabetes. 2014; 64(2):498-507.

PMID: 25157093 PMC: 4303973. DOI: 10.2337/db14-0825.

References

Fujimoto K, Fukagawa K, Sakata T, Tso P . Suppression of food intake by apolipoprotein A-IV is mediated through the central nervous system in rats. J Clin Invest. 1993; 91(4):1830-3. PMC: 288165. DOI: 10.1172/JCI116395. View

Fisher R, Burke H, Nicaud V, Ehnholm C, Humphries S . Effect of variation in the apo A-IV gene on body mass index and fasting and postprandial lipids in the European Atherosclerosis Research Study II. EARS Group. J Lipid Res. 1999; 40(2):287-94. View

Onat A, Can G, Cicek G, Ayhan E, Dogan Y . Predictive value of serum apolipoprotein B/LDL-cholesterol ratio in cardiometabolic risk: population-based cohort study. Clin Biochem. 2010; 43(18):1381-6. DOI: 10.1016/j.clinbiochem.2010.08.027. View

Dallongeville J, Delcroix A, Wagner A, Ducimetiere P, Ruidavets J, Arveiler D . The APOA4 Thr347->Ser347 polymorphism is not a major risk factor of obesity. Obes Res. 2006; 13(12):2132-8. DOI: 10.1038/oby.2005.264. View

Steinmetz A, Barbaras R, Ghalim N, Clavey V, Fruchart J, Ailhaud G . Human apolipoprotein A-IV binds to apolipoprotein A-I/A-II receptor sites and promotes cholesterol efflux from adipose cells. J Biol Chem. 1990; 265(14):7859-63. View

Liu M, Shen L, Tso P . The role of enterostatin and apolipoprotein AIV on the control of food intake. Neuropeptides. 2000; 33(5):425-33. DOI: 10.1054/npep.1999.0052. View

Onat A, Hergenc G, Keles I, Dogan Y, Turkmen S, Sansoy V . Sex difference in development of diabetes and cardiovascular disease on the way from obesity and metabolic syndrome. Metabolism. 2005; 54(6):800-8. DOI: 10.1016/j.metabol.2005.01.025. View

Brett K, Cooper G . Associations with menopause and menopausal transition in a nationally representative US sample. Maturitas. 2003; 45(2):89-97. DOI: 10.1016/s0378-5122(03)00139-7. View

Talmud P, Hawe E, Martin S, Olivier M, Miller G, Rubin E . Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides. Hum Mol Genet. 2002; 11(24):3039-46. DOI: 10.1093/hmg/11.24.3039. View

10.

Saha N, Wang G, Vasisht S, Kamboh M . Influence of two apo A4 polymorphisms at codons 347 and 360 on non-fasting plasma lipoprotein-lipids and apolipoproteins in Asian Indians. Atherosclerosis. 1997; 131(2):249-55. DOI: 10.1016/s0021-9150(97)06112-1. View

11.

Weinberg R, Patton C . Binding of human apolipoprotein A-IV to human hepatocellular plasma membranes. Biochim Biophys Acta. 1990; 1044(2):255-61. DOI: 10.1016/0005-2760(90)90311-k. View

12.

Onat A, Sari I, Yazici M, Can G, Hergenc G, Avci G . Plasma triglycerides, an independent predictor of cardiovascular disease in men: a prospective study based on a population with prevalent metabolic syndrome. Int J Cardiol. 2005; 108(1):89-95. DOI: 10.1016/j.ijcard.2005.06.056. View

13.

von Eckardstein A, Funke H, Schulte M, Erren M, Schulte H, Assmann G . Nonsynonymous polymorphic sites in the apolipoprotein (apo) A-IV gene are associated with changes in the concentration of apo B- and apo A-I-containing lipoproteins in a normal population. Am J Hum Genet. 1992; 50(5):1115-28. PMC: 1682587. View

14.

Wong W, Hawe E, Li L, Miller G, Nicaud V, Pennacchio L . Apolipoprotein AIV gene variant S347 is associated with increased risk of coronary heart disease and lower plasma apolipoprotein AIV levels. Circ Res. 2003; 92(9):969-75. DOI: 10.1161/01.RES.0000069688.94567.7A. View

15.

Lefevre M, Lovejoy J, DeFelice S, Keener J, Bray G, Ryan D . Common apolipoprotein A-IV variants are associated with differences in body mass index levels and percentage body fat. Int J Obes Relat Metab Disord. 2000; 24(8):945-53. DOI: 10.1038/sj.ijo.0801260. View

16.

Miltiadous G, Hatzivassiliou M, Bashiardes E, Bairaktari E, Cariolou M, Elisaf M . Genetic polymorphisms of the apolipoprotein A-IV in a Greek population and their relation to plasma lipid and lipoprotein levels. Clin Genet. 2002; 62(3):208-13. DOI: 10.1034/j.1399-0004.2002.620304.x. View

17.

Zaiou M, Visvikis S, Gueguen R, Parra H, Fruchart J, Siest G . DNA polymorphisms of human apolipoprotein A-IV gene: frequency and effects on lipid, lipoprotein and apolipoprotein levels in a French population. Clin Genet. 1994; 46(3):248-54. DOI: 10.1111/j.1399-0004.1994.tb04235.x. View

18.

Pai H, Chen H, Tsao L . The relationship among obesity, menopausal status, and health behavior among middle-aged women in a rural community of southern Taiwan. Health Care Women Int. 2010; 31(12):1097-109. DOI: 10.1080/07399332.2010.486456. View

19.

. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997; 20(7):1183-97. DOI: 10.2337/diacare.20.7.1183. View

20.

Chen C, Albers J . Activation of lecithin: cholesterol acyltransferase by apolipoproteins E-2, E-3, and A-IV isolated from human plasma. Biochim Biophys Acta. 1985; 836(3):279-85. DOI: 10.1016/0005-2760(85)90131-6. View